Joseph Mills, MD
Vascular Surgery · Houston, TXNPI 1730270679
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $23,368 of the $27,914 with a category attached, or 83.7%. Bayer accounts for 77.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $21,627 and has fallen 86.4% since, to $2,942 in 2025.
Across 50 payments — averaging $558.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$22K
- Amgen$2K
- W. L. Gore & Associates, Inc.$1K
- Medtronic$777
- Cook Medical LLC$418
- Cardiva Medical, Inc.$412
- plus $2K from 13 others
Across 5 payments — averaging $13,195 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$52K
- Bayer$14K
What the payments were for
- Consulting fees$23,36884%
- Food & beverage$4,54716%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 1 | $21,500 |
| Amgen | 2 | $1,868 |
| W. L. Gore & Associates, Inc. | 8 | $1,117 |
| Medtronic(2 entities) | 8 | $777 |
| Cook Medical LLC | 5 | $418 |
| Cardiva Medical, Inc. | 4 | $412 |
| BD | 3 | $381 |
| Bard Peripheral Vascular, Inc. | 2 | $228 |
| Abbott | 3 | $211 |
| Angiodynamics, Inc. | 2 | $166 |
| Inari Medical, Inc. | 1 | $150 |
| Penumbra, Inc. | 1 | $141 |
| Smith+Nephew | 1 | $122 |
| Medline Industries LP | 4 | $118 |
| Shockwave Medical, Inc | 1 | $111 |
| GRT US Holding, Inc. | 1 | $72 |
| TEI Medical Inc. | 1 | $58 |
| Boston Scientific | 1 | $50 |
| Avinger Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$21,500
- ENDURANT IIS$403
- GORE VIABAHN VBX Balloon Expandable Endo$272
- EXCLUDER AAA Endoprosthesis$258
- C3 Delivery System$174
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$152
- FLOWTRIEVER CATHETER, S$150
- CT THROMBECTOMY SYSTEM KIT$150
- Lutonix Drug Coated Balloon$144
- Crosser iQ$142
- Penumbra System$141
- Aptus Heli-FX$124
- Cook Medical AAA$123
- CARDIVA VASCADE MVP XL VVCS 10-12F$122
- Stravix$122
- LIFESTREAM$122
- Cardiva VASCADE 5F VCS$121
- RotarexS 6 F x 135 cm$117
- Diamondback Peripheral$117
- VIABAHN VBX Balloon Expandable Endoprosthesis$113
How this compares
$27,914 in reported general payments places this provider in the 80th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in Houston
- Alan LumsdenHouston$742K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Ali AzizzadehHouston$181K
- Steven MaximusHouston$140K
- Samuel LeonardHouston$96K
- Charudatta BavareHouston$72K
- Philip AuyangHouston$43K
- Jayer ChungHouston$42K
- Rana AfifiHouston$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.